Trial Details

UNKNOWN
Basic Information
Clinical ID c253
Identifier NCT03308357
Trial Title Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DIAGNOSTIC_TEST: Drug assays to measure infliximab
Participant Information
Sponsor The Alfred
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-10-17
Primary Completion Date 2025-03-18
Completion Date 2025-03-18